loading
Precedente Chiudi:
$1.77
Aprire:
$1.68
Volume 24 ore:
5,127
Relative Volume:
0.13
Capitalizzazione di mercato:
$9.97M
Reddito:
-
Utile/perdita netta:
$-2.25M
Rapporto P/E:
-3.5504
EPS:
-0.476
Flusso di cassa netto:
-
1 W Prestazione:
-7.14%
1M Prestazione:
-13.55%
6M Prestazione:
-39.64%
1 anno Prestazione:
+64.08%
Intervallo 1D:
Value
$1.6743
$1.83
Intervallo di 1 settimana:
Value
$1.6743
$1.85
Portata 52W:
Value
$0.76
$4.9897

X T L Biopharmaceuticals Ltd Adr Stock (XTLB) Company Profile

Name
Nome
X T L Biopharmaceuticals Ltd Adr
Name
Telefono
-
Name
Indirizzo
-
Name
Dipendente
4
Name
Cinguettio
@xtlbio
Name
Prossima data di guadagno
2024-05-24
Name
Ultimi documenti SEC
Name
XTLB's Discussions on Twitter

Confronta XTLB con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
XTLB 1.83 9.97M 0 -2.25M 0 -0.476
VRTX 449.72 115.43B 10.63B -479.80M -1.35B 13.33
REGN 747.06 82.04B 13.85B 4.65B 3.32B 35.06
ARGX 595.00 35.30B 1.86B -40.29M -1.28B -4.16
ALNY 246.52 32.04B 2.09B -332.26M 16.06M -4.14
BNTX 108.14 24.89B 3.30B -501.07M 1.03B 11.54

X T L Biopharmaceuticals Ltd Adr Stock (XTLB) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2015-05-08 Iniziato H.C. Wainwright Buy

X T L Biopharmaceuticals Ltd Adr Borsa (XTLB) Ultime notizie

pulisher
Nov 19, 2024

XTL Biopharmaceuticals Adjusts Shares, Eyes Expansion - TipRanks

Nov 19, 2024
pulisher
Nov 12, 2024

XTL Biopharmaceuticals Resolves Dispute with Social Proxy - TipRanks

Nov 12, 2024
pulisher
Oct 27, 2024

U.S. shares higher at close of trade; Dow Jones Industrial Average up 1.03% - MSN

Oct 27, 2024
pulisher
Oct 15, 2024

XTL Biopharmaceuticals Faces Financial Dispute After Acquisition - TipRanks

Oct 15, 2024
pulisher
Aug 14, 2024

XTL Biopharmaceuticals Expands with AI Company Acquisition - TipRanks

Aug 14, 2024
pulisher
Jul 22, 2024

XTL Biopharmaceuticals Confirms Board and Auditor Appointments - Investing.com

Jul 22, 2024
pulisher
Jul 22, 2024

XTL Biopharmaceuticals Announces Shareholder Meeting Outcomes - TipRanks

Jul 22, 2024
pulisher
Jun 19, 2024

A stock that deserves closer examination: X.T.L. Biopharmaceuticals Ltd. ADR (XTLB) – US Post News - US Post News

Jun 19, 2024
pulisher
Jun 12, 2024

XTL Biopharmaceuticals Announces Upcoming Shareholder MeetingTipRanks.com - TipRanks

Jun 12, 2024
pulisher
Jun 05, 2024

XTL Biopharmaceuticals acquires AI firm Social Proxy By Investing.com - Investing.com

Jun 05, 2024
pulisher
Jun 05, 2024

XTL Biopharmaceuticals acquires AI firm Social Proxy - Investing.com India

Jun 05, 2024
pulisher
Jun 05, 2024

XTL Biopharmaceuticals Acquires SOCIAL PROXY LTD.TipRanks.com - TipRanks

Jun 05, 2024
pulisher
Jun 05, 2024

XTL Entered Definitive Agreement to Acquire The Social Proxy - GlobeNewswire Inc.

Jun 05, 2024
pulisher
May 30, 2024

Market Recap: X.T.L. Biopharmaceuticals Ltd. ADR (XTLB)'s Positive Momentum, Closing at 2.62 – DWinneX - The Dwinnex

May 30, 2024
pulisher
May 14, 2024

XTL Biopharmaceuticals Expands Portfolio Amidst Profitable QuarterTipRanks.com - TipRanks

May 14, 2024
pulisher
Apr 02, 2024

XTL Biopharmaceuticals Regains Nasdaq ComplianceTipRanks.com - TipRanks

Apr 02, 2024
pulisher
Mar 21, 2024

XTL Biopharmaceuticals Convenes Extraordinary General MeetingTipRanks.com - TipRanks

Mar 21, 2024
pulisher
Mar 21, 2024

Enhance Your Investment Strategy with Altman Z-Score Screener By Investing.com - Investing.com India

Mar 21, 2024
pulisher
Mar 20, 2024

XTL Biopharmaceuticals Acquires The Social Proxy - TipRanks

Mar 20, 2024
pulisher
Jan 14, 2021

The Daily Biotech Pulse: Alexion Pauses COVID-19 Study, NantKwest Readout, Organogenesis Jumps On Guidanc - Benzinga

Jan 14, 2021
pulisher
Dec 18, 2020

The Daily Biotech Pulse: FDA Nod For Amgen's Biosimilar, Moderna's Vaccine Vote, Mesoblast Sinks On Data - Benzinga

Dec 18, 2020
pulisher
Sep 10, 2020

The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Sarepta Flags Potential Delay In Gene Therapy Trial - Benzinga

Sep 10, 2020
pulisher
Mar 19, 2020

The Daily Biotech Pulse: Pfizer's Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadic's COVID-19 Connection - Yahoo Finance

Mar 19, 2020
pulisher
Mar 12, 2020

List of US Companies Releasing Earnings (EPS) Today - FX Leaders

Mar 12, 2020
pulisher
Mar 11, 2020

The Daily Biotech Pulse: NY State Endorses Mallinckrodt's Opioid Settlement, Kamada To Work On COVID-19 T - Benzinga

Mar 11, 2020
pulisher
Mar 10, 2020

The Daily Biotech Pulse: Mesoblast To Test Candidate On Coronavirus Symptoms, Proxy Battle Ahead For Rock - Benzinga

Mar 10, 2020
pulisher
Nov 21, 2019

The Daily Biotech Pulse: Patent Win For Cellectis, Hepion Proves Efficacy In Animal Model, Job Cuts At Neon - Yahoo Finance

Nov 21, 2019
pulisher
May 01, 2018

Benzinga's Daily Biotech Pulse: Karyopharm's STORM Study, Inogen Rallies On Earnings - Yahoo Finance

May 01, 2018
pulisher
Mar 09, 2017

15 Biggest Mid-Day Gainers For ThursdayCuris (NASDAQ:CRIS), Federal Agricultural (NYSE:AGM), Canadian - Benzinga

Mar 09, 2017
pulisher
Feb 17, 2017

Mid-Afternoon Market Update: Monotype Drops On Earnings Miss; LMI Aerospace Shares Spike HigherDeere ( - Benzinga

Feb 17, 2017
pulisher
Jan 04, 2016

Mid-Morning Market Update: Markets Open Lower; Tesla Motors Delivers 17,400 Vehicles in Fourth Quarter - Benzinga

Jan 04, 2016
pulisher
Aug 26, 2015

Morning Market LosersCentury Aluminum (NASDAQ:CENX) - Benzinga

Aug 26, 2015

X T L Biopharmaceuticals Ltd Adr Azioni (XTLB) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$18.98
price up icon 1.80%
$70.68
price down icon 0.42%
$38.38
price up icon 3.49%
$369.83
price up icon 1.48%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
Capitalizzazione:     |  Volume (24 ore):